Thermo Fisher Scientific

  1. Accelerating Science
  2. Behind the Bench
    3. /
  3. Events and Tradeshows
    4. / cfDNA & CTC by the LiquidBiopsy Platform | AACR 2015

cfDNA & CTC by the LiquidBiopsy Platform | AACR 2015

Written by | Published: 04.21.2015

The American Association for Cancer Research exhibit hall debuted the new LiquidBiopsy™ Platform, and in this video Vidya Venkatesh (Thermo Fisher Scientific) shares the advantages of this system.

From collection and stabilization to excellent recovery and downstream analysis this system isolates both cell-free DNA (cfDNA) and circulating tumor cells (CTCs) from a single whole-blood sample.

More information about the LiquidBiopsy Platform is available online.

Leave a Reply

Your email address will not be published. Required fields are marked *

Get news and research reviews on the topic of your choice, right in your inbox.

Subscribe Now

  • This field is for validation purposes and should be left unchanged.